moclobemide has been researched along with Abdominal Migraine in 5 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While on this therapy, 35 of the 42 migraine patients and 16 of the 17 patients with tension-type headache experienced good or very good improvement in their symptoms." | 5.30 | [Preventive treatment of migraine and chronic tension headache with moclobemide]. ( Amsler, F; Meienberg, O, 1997) |
| "Mean almotriptan AUC was higher (483 +/- 99." | 2.70 | Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. ( Azie, NE; Bell, DJ; Burke, MT; Carel, BJ; Fleishaker, JC; Jansat, JM; Ryan, KK, 2001) |
| "Frequent and recurrent migraine headaches can, over time, pose the additional risks of stroke, brain damage, heart failure and attention deficit." | 1.33 | A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients. ( Eli, R; Fasciano, JA, 2006) |
| "While on this therapy, 35 of the 42 migraine patients and 16 of the 17 patients with tension-type headache experienced good or very good improvement in their symptoms." | 1.30 | [Preventive treatment of migraine and chronic tension headache with moclobemide]. ( Amsler, F; Meienberg, O, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eli, R | 1 |
| Fasciano, JA | 1 |
| Claman, JM | 1 |
| Meienberg, O | 2 |
| Amsler, F | 2 |
| Fleishaker, JC | 1 |
| Ryan, KK | 1 |
| Jansat, JM | 1 |
| Carel, BJ | 1 |
| Bell, DJ | 1 |
| Burke, MT | 1 |
| Azie, NE | 1 |
1 trial available for moclobemide and Abdominal Migraine
| Article | Year |
|---|---|
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
Topics: Adolescent; Adult; Cross-Over Studies; Drug Interactions; Female; Humans; Indoles; Male; Middle Aged | 2001 |
4 other studies available for moclobemide and Abdominal Migraine
| Article | Year |
|---|---|
A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients.
Topics: Antioxidants; Headache Disorders; Humans; Hydrocortisone; Melatonin; Migraine Disorders; Moclobemide | 2006 |
The potential effectiveness of moclobemide, the new monoamine oxidase inhibitor, in the prophylaxis of migraine.
Topics: Adult; Benzamides; Female; Humans; Migraine Disorders; Moclobemide; Monoamine Oxidase Inhibitors | 1993 |
Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.
Topics: Analgesics; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy | 1996 |
[Preventive treatment of migraine and chronic tension headache with moclobemide].
Topics: Adult; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Headache; | 1997 |